ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
6.57
+0.33 (5.29%)
At close: Jan 8, 2026, 4:00 PM EST
6.37
-0.20 (-3.04%)
Pre-market: Jan 9, 2026, 6:00 AM EST
ImmuCell Market Cap
ImmuCell has a market cap or net worth of $59.43 million as of January 9, 2026. Its market cap has increased by 45.61% in one year.
Market Cap
59.43M
Enterprise Value
69.15M
1-Year Change
45.61%
Ranking
Category
Stock Price
$6.57
Market Cap Chart
Since May 1, 1992, ImmuCell's market cap has increased from $1.99M to $59.43M, an increase of 2,883.50%. That is a compound annual growth rate of 10.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 56.45M | 1.46% |
| Dec 31, 2025 | 55.63M | 21.22% |
| Dec 31, 2024 | 45.89M | 16.33% |
| Dec 29, 2023 | 39.45M | -16.51% |
| Dec 30, 2022 | 47.26M | -23.70% |
| Dec 31, 2021 | 61.94M | 44.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 933.74B |
| Johnson & Johnson | 495.28B |
| AbbVie | 391.88B |
| UnitedHealth Group | 316.59B |
| AstraZeneca | 280.51B |
| Merck & Co. | 270.74B |
| Novartis AG | 262.61B |
| Novo Nordisk | 241.55B |